{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:31:02Z","timestamp":1780497062453,"version":"3.54.1"},"reference-count":56,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Objective: To investigate the long-term effects of intravenous neridronate treatment in patients with complex regional pain syndrome type 1 (CRPS) in a real-life setting. Methods: We conducted a retrospective study on consecutive CRPS patients treated at our hospital from February 2018 to July 2023. All were treated within three months of the onset of CRPS symptoms. The Patient-Reported Outcomes Measurement Information System 29-Item Health Profile (PROMIS-29) version 2.1 was administered. The main outcome of interest was the evolution of the PROMIS-29 scores from baseline to the last follow-up visit. Patients were categorized as \u201ccomplete responders\u201d or \u201cnon-complete responders\u201d. The association of clinical and demographic variables with a complete response was analyzed using chi-square tests and univariate logistic regression. Results: Thirty-six patients were included, with a median follow-up time of 4.8 years. A significant improvement was noted in the mean numerical pain rating scale (from 6.4 \u00b1 1.9 to 3.1 \u00b1 2.4, p &lt; 0.001), as well as across all PROMIS-29 domains. Physical function improved from 34.2 \u00b1 4.9 to 49.2 \u00b1 9.9, p &lt; 0.001; anxiety from 58.0 \u00b1 6.7 to 49.6 \u00b1 6.9, p &lt; 0.001; depression from 55.3 \u00b1 6.3 to 47.7 \u00b1 6.6, p &lt; 0.001; fatigue from 55.7 \u00b1 7.7 to 50.9 \u00b1 8.7, p &lt; 0.001; sleep disturbance from 53.8 \u00b1 6.8 to 51.3 \u00b1 6.6, p = 0.034; social roles and activities from 41.8 \u00b1 5.2 to 51.8 \u00b1 8.9, p &lt; 0.001; and pain interference from 64.1 \u00b1 5.9 to 52.4 \u00b1 9.9, p &lt; 0.001. The likelihood of achieving a complete response was associated with the male sex, foot or ankle injuries (compared to hand and wrist injuries), and a younger age. No association was found with the type of inciting event or with the body mass index. Conclusions: Our real-life data indicate that early treatment with neridronate leads to substantial benefits in patients affected by CRPS type 1. The strongest responses are seen in young patients, males, and those with lower limb involvement.<\/jats:p>","DOI":"10.3390\/ph17111500","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T04:02:54Z","timestamp":1731038574000},"page":"1500","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-7351","authenticated-orcid":false,"given":"Jacopo","family":"Ciaffi","sequence":"first","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40127 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Festuccia","sequence":"additional","affiliation":[{"name":"Physical Medicine and Rehabilitation Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ripamonti","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-2443","authenticated-orcid":false,"given":"Luana","family":"Mancarella","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Brusi","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pignatti","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lisi","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Berti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40127 Bologna, Italy"},{"name":"Physical Medicine and Rehabilitation Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-8551","authenticated-orcid":false,"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-4778","authenticated-orcid":false,"given":"Cesare","family":"Faldini","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40127 Bologna, Italy"},{"name":"1st Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-8642","authenticated-orcid":false,"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[{"name":"Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40127 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40122-021-00279-4","article-title":"Complex Regional Pain Syndrome: A Comprehensive Review","volume":"10","author":"Taylor","year":"2021","journal-title":"Pain Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.autrev.2013.10.006","article-title":"Complex regional pain syndrome: A comprehensive and critical review","volume":"13","author":"Borchers","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s40141-023-00426-2","article-title":"Complex Regional Pain Syndrome: Updates and Current Evidence","volume":"12","author":"Her","year":"2024","journal-title":"Curr. Phys. Med. Rehabil. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.56.3.201","article-title":"Bisphosphonate therapy of reflex sympathetic dystrophy syndrome","volume":"56","author":"Adami","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1526-4637.2004.04038.x","article-title":"Efficacy of Pamidronate in Complex Regional Pain Syndrome Type I","volume":"5","author":"Robinson","year":"2004","journal-title":"Pain Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.20591","article-title":"Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity","volume":"50","author":"Manicourt","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_7","first-page":"1477","article-title":"Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study","volume":"27","author":"Varenna","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/kes312","article-title":"Treatment of complex regional pain syndrome type I with neridronate: A randomized, double-blind, placebo-controlled study","volume":"52","author":"Varenna","year":"2013","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1759720X2110140","DOI":"10.1177\/1759720X211014020","article-title":"Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: A randomized, double-blind, placebo-controlled study","volume":"13","author":"Varenna","year":"2021","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_10","first-page":"30","article-title":"Pamidronate effect compared with a steroid on complex regional pain syndrome type I: Pilot randomised trial","volume":"74","author":"Hyeyun","year":"2016","journal-title":"Neth. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1002\/ejoc.200601067","article-title":"Syntheses of Phosphonic Esters of Alendronate, Pamidronate and Neridronate","volume":"2007","author":"Monteil","year":"2007","journal-title":"Eur. J. Org. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.beem.2008.07.001","article-title":"Bisphosphonates: How do they work?","volume":"22","author":"Papapoulos","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1093\/rheumatology\/keac060","article-title":"Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomized controlled trials","volume":"61","author":"Fassio","year":"2022","journal-title":"Rheumatology"},{"key":"ref_14","first-page":"451","article-title":"Bisphosphonates in Complex Regional Pain syndrome type I: How do they work?","volume":"32","author":"Varenna","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000056","DOI":"10.1136\/rmdopen-2015-000056","article-title":"Treatment of complex regional pain syndrome type I with bisphosphonates","volume":"1","author":"Giusti","year":"2015","journal-title":"RMD Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1759720X2211422","DOI":"10.1177\/1759720X221142274","article-title":"Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: A pre-specified, open-label, extension study","volume":"14","author":"Varenna","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_17","first-page":"961","article-title":"Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome","volume":"42","author":"Adami","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_18","first-page":"1131","article-title":"Predictors of Responsiveness to Bisphosphonate Treatment in Patients with Complex Regional Pain Syndrome Type I: A Retrospective Chart Analysis","volume":"18","author":"Varenna","year":"2016","journal-title":"Pain Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/pm\/pny279","article-title":"Core Outcome Measures for Chronic Musculoskeletal Pain Research: Recommendations from a Veterans Health Administration Work Group","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12998-020-00320-x","article-title":"PROMIS\u00ae General Life Satisfaction scale: Construct validity in musculoskeletal pain patients","volume":"28","author":"Vaughan","year":"2020","journal-title":"Chiropr. Man. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jso.27386","article-title":"Patient-reported outcome tools in musculoskeletal oncology","volume":"128","author":"Vijayakumar","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jocn.2023.05.017","article-title":"Prednisolone 20 mg vs 40 mg in complex regional pain syndrome type I: A randomized controlled trial","volume":"113","author":"Kalita","year":"2023","journal-title":"J. Clin. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/qjmed\/hcl004","article-title":"Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: A randomized controlled trial","volume":"99","author":"Kalita","year":"2006","journal-title":"QJM Int. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.36076\/ppj\/2016.19.565","article-title":"Long-term Prednisolone in Post-stroke Complex Regional Pain Syndrome","volume":"19","author":"Kalita","year":"2016","journal-title":"Pain Physician"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8182569","DOI":"10.1155\/2020\/8182569","article-title":"Prednisone for Acute Complex Regional Pain Syndrome: A Retrospective Cohort Study","volume":"2020","author":"Jamroz","year":"2020","journal-title":"Pain Res. Manag."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09629350210307","article-title":"Evidence for local inflammation in complex regional pain syndrome type 1","volume":"11","author":"Huygen","year":"2002","journal-title":"Mediat. Inflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2174\/138161210793563635","article-title":"Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages","volume":"16","author":"Roelofs","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bcp.2006.09.031","article-title":"Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro","volume":"73","author":"Moreau","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"Rogers","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/odi.12908","article-title":"Alteration of macrophage viability, differentiation, and function by bisphosphonates","volume":"24","author":"Patntirapong","year":"2018","journal-title":"Oral Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpain.2014.01.490","article-title":"Activation of Cutaneous Immune Responses in Complex Regional Pain Syndrome","volume":"15","author":"Birklein","year":"2014","journal-title":"J. Pain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10286-019-00612-0","article-title":"Complex regional pain syndrome: A focus on the autonomic nervous system","volume":"29","author":"Knudsen","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(11)70106-5","article-title":"Clinical features and pathophysiology of complex regional pain syndrome","volume":"10","author":"Marinus","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7697214","DOI":"10.1155\/2020\/7697214","article-title":"Molecular Aspects of Regional Pain Syndrome","volume":"2020","author":"Baronio","year":"2020","journal-title":"Pain Res. Manag."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08998280.2016.11929460","article-title":"Complex Regional Pain Syndrome","volume":"29","author":"Carr","year":"2016","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/pmj.77.910.519","article-title":"A study of bone densitometry in patients with complex regional pain syndrome after stroke","volume":"77","author":"Kumar","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.11138\/ccmbm\/2017.14.1.054","article-title":"Evaluation of bone microstructure in CRPS-affected upper limbs by HR-pQCT","volume":"14","author":"Mussawy","year":"2017","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pain.2010.04.030","article-title":"Validation of proposed diagnostic criteria (the \u201cBudapest Criteria\u201d) for Complex Regional Pain Syndrome","volume":"150","author":"Harden","year":"2010","journal-title":"Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/j.pain.0000000000000569","article-title":"Complex regional pain syndrome: Evidence for warm and cold subtypes in a large prospective clinical sample","volume":"157","author":"Bruehl","year":"2016","journal-title":"Pain"},{"key":"ref_40","unstructured":"(2014). General Assembly of the World Medical Association World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J. Am. Coll. Dent., 81, 14\u201318."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years","volume":"45","author":"Cella","year":"2007","journal-title":"Med. Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/j.pain.0000000000000866","article-title":"Recommendations for a first Core Outcome Measurement set for complex regional PAin syndrome Clinical sTudies (COMPACT)","volume":"158","author":"Grieve","year":"2017","journal-title":"Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0304-3959(85)90045-4","article-title":"Semantics of pain in Italy: The Italian version of the McGill Pain Questionnaire","volume":"22","author":"Maiani","year":"1985","journal-title":"Pain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"114519","DOI":"10.1016\/j.socscimed.2021.114519","article-title":"An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration","volume":"292","author":"Finch","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/papr.12242","article-title":"The Pain Self-Efficacy Questionnaire: Cross-Cultural Adaptation into Italian and Assessment of Its Measurement Properties","volume":"15","author":"Chiarotto","year":"2015","journal-title":"Pain Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11136-011-0007-4","article-title":"Development of the Italian version of the Pain Catastrophising Scale (PCS-I): Cross-cultural adaptation, factor analysis, reliability, validity and sensitivity to change","volume":"21","author":"Monticone","year":"2012","journal-title":"Qual. Life Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/09645284221118589","article-title":"An audit of structure-based medical acupuncture by a single provider in patients with musculoskeletal pain using PROMIS scores as the outcome","volume":"41","author":"Tang","year":"2023","journal-title":"Acupunct. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/BRS.0000000000003724","article-title":"Responsiveness of the PROMIS-29 Scales in Individuals With Chronic Low Back Pain","volume":"46","author":"Khutok","year":"2021","journal-title":"Spine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002508-200309000-00001","article-title":"What Is a Meaningful Pain Reduction in Patients with Complex Regional Pain Syndrome Type 1?","volume":"19","author":"Forouzanfar","year":"2003","journal-title":"Clin. J. Pain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The Pain Catastrophizing Scale: Development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol. Assess."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","article-title":"Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)","volume":"144","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","article-title":"The pain self-efficacy questionnaire: Taking pain into account","volume":"11","author":"Nicholas","year":"2007","journal-title":"Eur. J. Pain"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-SD: A measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jval.2013.10.006","article-title":"From Translation to Version Management: A History and Review of Methods for the Cultural Adaptation of the EuroQol Five-Dimensional Questionnaire","volume":"17","author":"Rabin","year":"2014","journal-title":"Value Health"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to Pharmacometric Graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharmacol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1500\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:28:29Z","timestamp":1760113709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ph17111500"],"URL":"https:\/\/doi.org\/10.3390\/ph17111500","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}